1. Home
  2. MYN vs MRVI Comparison

MYN vs MRVI Comparison

Compare MYN & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MYN
  • MRVI
  • Stock Information
  • Founded
  • MYN 1992
  • MRVI 2014
  • Country
  • MYN United States
  • MRVI United States
  • Employees
  • MYN N/A
  • MRVI N/A
  • Industry
  • MYN Finance Companies
  • MRVI Biotechnology: Pharmaceutical Preparations
  • Sector
  • MYN Finance
  • MRVI Health Care
  • Exchange
  • MYN Nasdaq
  • MRVI Nasdaq
  • Market Cap
  • MYN 358.2M
  • MRVI 312.4M
  • IPO Year
  • MYN N/A
  • MRVI 2020
  • Fundamental
  • Price
  • MYN $9.37
  • MRVI $2.61
  • Analyst Decision
  • MYN
  • MRVI Hold
  • Analyst Count
  • MYN 0
  • MRVI 10
  • Target Price
  • MYN N/A
  • MRVI $5.84
  • AVG Volume (30 Days)
  • MYN 86.0K
  • MRVI 1.7M
  • Earning Date
  • MYN 01-01-0001
  • MRVI 08-11-2025
  • Dividend Yield
  • MYN 4.12%
  • MRVI N/A
  • EPS Growth
  • MYN N/A
  • MRVI N/A
  • EPS
  • MYN N/A
  • MRVI N/A
  • Revenue
  • MYN N/A
  • MRVI $219,830,000.00
  • Revenue This Year
  • MYN N/A
  • MRVI N/A
  • Revenue Next Year
  • MYN N/A
  • MRVI $10.70
  • P/E Ratio
  • MYN N/A
  • MRVI N/A
  • Revenue Growth
  • MYN N/A
  • MRVI N/A
  • 52 Week Low
  • MYN $8.47
  • MRVI $1.67
  • 52 Week High
  • MYN $10.62
  • MRVI $9.95
  • Technical
  • Relative Strength Index (RSI)
  • MYN 50.46
  • MRVI 55.37
  • Support Level
  • MYN $9.12
  • MRVI $2.56
  • Resistance Level
  • MYN $9.47
  • MRVI $2.79
  • Average True Range (ATR)
  • MYN 0.08
  • MRVI 0.18
  • MACD
  • MYN 0.02
  • MRVI 0.04
  • Stochastic Oscillator
  • MYN 69.44
  • MRVI 77.50

About MYN Blackrock MuniYield New York Quality Fund Inc.Common Stock

Blackrock Muniyield NY Quality FD, Inc is a closed-end management investment company. Its objective is to provide shareholders with a high level of current income exempt from federal income taxes. The Fund invests in long-term municipal obligations that are investment grade quality or are considered by the Fund's investment adviser to be of comparable quality, at the time of investment.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Share on Social Networks: